About
Technology
Issues
FAQ
Links
Official Page
AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon–Small-Cell Lung Cancer With
EGFR
Exon 19 Deletion or L858R Mutations
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.